Global Nuclear Imaging Market
According to the report“ Nuclear Imaging Market ", published by Market Data Forecast, the global market is projected to reach USD 15.34 billion by 2021, at a CAGR of 8.87 % from 2016 to 2021.
Medical imaging is the method of making a visual image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.
Nuclear imaging is most commonly utilized for cardiovascular and oncology applications. It refers to the method of generating visuals of the organs of the body by processing minor quantity of radioactive tracers. The images are obtained using a gamma camera and can be documented on film or on a computer.
The growth of the Global Nuclear Imaging market is mainly due to factors such as an increase in the number of cancer and cardiovascular disease cases, predilection towards minimally invasive procedures, ready availability of radiopharmaceuticals, and improving healthcare infrastructure in developing markets. However, factors such as costly procedures & equipment, inadequate number of trained medical staffs, and shortage of supplies are hampering the growth of the market.
Global Market for Nuclear Imaging is segmented based on Technology, Application and region
1. Based on Diagnostic Technologies:
� PET Radioisotopes a. Rubidium-82 b. Fluorine-18 c. Others
�
SPECT Radioisotopes a. Thallium-201 b. Technetium-99m c. Xenon-133 d. Iodine-123 e. Others
2. Based on Application: �
PET
+ 1 888-702-9626 | www. marketdataforecast. com | contact @ marketdataforecast. com